drugset / Trial / NCT00564681

Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia

NCT00564681 ↗

Phase 2 Completed 242 enrolled Allergan
RandomizedParallel-groupDouble-blindTreatment

Summary

Study is to investigate the use of the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scale in a cervical dystonia population treated with botulinum toxin type A, and placebo.

Timeline

Start
2007-12
Primary completion
2008-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 360 iu Intramuscular

Indications